AI assistant
Sending…
Perspective Therapeutics, Inc. — Director's Dealing 2010
Oct 18, 2010
33510_dirs_2010-10-18_40a4d307-5d2d-43d3-8dd9-b4609aab0acb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2010-10-07
Reporting Person: Cavanagh William (Vice President)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $0.84 | 2020-01-08 | common stock (30000) | Direct | |
| Stock Option | $1.43 | 2020-06-30 | common stock (35000) | Direct |
Footnotes
F1: Vests 1/3 on 1/18/2011, 1/3 on 1/8/2012, and 1/3 on 1/8/2013.
F2: Vests 1/3 on 6/30/2011, 1/3 on 6/30/2012, and 1/3 on 6/30/2013.
More from Perspective Therapeutics, Inc.
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 12
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 27
Regulatory Filings
2026
Apr 20
Proxy Solicitation & Information Statement
2026
Apr 16